Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck income from Discontinued Operations, Net of Taxes (Organon Spin-Off) ($M) ($M)
Postgres DB financial_values
Latest, Q4 2022
0
Period ended Dec 31, 2022
Change on a year earlier
-100.0%
-62 in Q4 2021
History
11 quarters
Since Q2 2020
Sources
7
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Income from Discontinued Operations, Net of Taxes (Organon Spin-Off) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2022 | Dec 31, 2022 | 0 | -100.0% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 0 | – | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 0 | -100.0% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 0 | -100.0% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | -62 | -111.9% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 0 | -100.0% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 332 | -50.1% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 437 | – | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 523 | – | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 619 | – | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 665 | – | Form 10-Q (filed 2021-08-09) ↗ |
Cite this data
StockData. (2026). Merck Income from Discontinued Operations, Net of Taxes (Organon Spin-Off) ($M) ($M), quarterly Q2 2020–Q4 2022 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_inc_disc_ogn
See every metric in the Merck KPI table. Data updated Oct 26, 2026.